The era of prompt-to-production software is here, but for larger enterprises, a lingering question often blocks adoption: ...
Emergent, the fast-growing AI software creation platform that helps founders and business owners build full-stack, production ...
Meta Platforms, Inc. (NASDAQ:META) launched the Meta Enterprise Platform on September 28 as a new business pillar focused on ...
Meta Platforms, Inc.’s new AI launches clarify monetization as Muse and business tools scale. Click for this META stock ...
AWS Database Migration Service AWS DMS was originally designed for a specific task: lifting relational databases off on-premises servers and moving them into managed Amazon ...
NVIDIA Safety FoundationYesterday (September 28) in global AI news was a day where "how to stop runaway agents" became a ...
When we see the announcement of a new AI service, we want to know 'what it can do that the current service cannot.' For ...
Spread the loveData science is no longer just a buzzword; it’s a fundamental component of decision-making across industries. With the increasing amount of data available, mastering how to analyze and ...
NeOnc Technologies Holdings Sets November 17 FDA End-of-Phase 1 Meeting for Brain-Cancer Drug NEO212
NeOnc Technologies plans a critical FDA meeting on November 17 regarding their brain-cancer drug NEO212's development.
Cohere has released Embed 5 Pro and Embed 5 Fast, a new family of embedding models designed to improve enterprise document retrieval while giving businesses more control over inference costs, latency ...
Muse for Small Business connects Meta’s AI agent to ad accounts, Instagram analytics, Shopify, QuickBooks and Stripe, and ...
Cellectar Biosciences reports promising iopofosine I 131 results for WM patients post-BTKi therapy, advancing toward Phase 3 trial and accelerated approval.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results